LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.95 | 84.90 | 4699 | 4952 | 0.9488 | 0.9822 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.95 | 84.90 | 4682 | 4952 | 0.9454 | 0.9809 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.95 | 84.90 | 4858 | 4952 | 0.9809 | 0.9934 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 48.65 | 84.90 | 4959 | 5328 | 0.9306 | 0.9761 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 48.65 | 84.90 | 5039 | 5328 | 0.9456 | 0.9814 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 48.65 | 84.90 | 5077 | 5328 | 0.9527 | 0.9839 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 48.65 | 84.90 | 5207 | 5328 | 0.9771 | 0.9923 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 50.36 | 84.90 | 5338 | 5651 | 0.9446 | 0.9813 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 50.36 | 84.90 | 5433 | 5651 | 0.9614 | 0.9871 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 50.36 | 84.90 | 5375 | 5651 | 0.9511 | 0.9835 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 50.36 | 84.90 | 5576 | 5651 | 0.9867 | 0.9956 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 52.06 | 84.90 | 5578 | 5990 | 0.9311 | 0.9769 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 52.06 | 84.90 | 5681 | 5990 | 0.9483 | 0.9828 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 52.06 | 84.90 | 5572 | 5990 | 0.9301 | 0.9765 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 52.06 | 84.90 | 5814 | 5990 | 0.9705 | 0.9903 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 53.77 | 84.90 | 5909 | 6252 | 0.9450 | 0.9819 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 53.77 | 84.90 | 6029 | 6252 | 0.9642 | 0.9883 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 53.77 | 84.90 | 5748 | 6252 | 0.9193 | 0.9731 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 53.77 | 84.90 | 6182 | 6252 | 0.9887 | 0.9963 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 55.48 | 84.90 | 6169 | 6567 | 0.9393 | 0.9801 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 55.48 | 84.90 | 6310 | 6567 | 0.9607 | 0.9873 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 55.48 | 84.90 | 5528 | 6567 | 0.8417 | 0.9458 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 55.48 | 84.90 | 6407 | 6567 | 0.9755 | 0.9921 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 57.18 | 84.90 | 6453 | 6963 | 0.9267 | 0.9762 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 57.18 | 84.90 | 6595 | 6963 | 0.9471 | 0.9830 | MN20160318_Q02 | E03 |